Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
136 Cards in this Set
- Front
- Back
Ureteral Bud |
•Starts as outpouching of wolffians •Kidneys migrate up from pelvis |
|
Urogenital Sinus 6 Wks Mens |
•Caudal end narrows/elongates •Forms urethra/neck of bladder |
|
Allantois |
•Forms the rest of the bladder |
|
Ureteral Bud Grows & Branches |
•Ureter, pelvis, calyces, tubules •W/o bud, kidneys don't form |
|
Nephrons |
•10 mens wks, 3-5 bud branchings •Seen 15 wks, 13 on TV |
|
Normal Kidneys |
•Hypoechoic cortex •See sinus fat & pyramids develop |
|
Kidney Development |
•Pelvis may dilate, not > 6mm •NL size in Trans: 1/3 of fetal abd |
|
Amniotic Fluid Volume Controlled By |
•Renal output in 2nd half of gestation •Normal with at least 1 NL kidney |
|
Polyhydramnios |
•CNS ABNL, poor swallowing •Upper GI ABNL |
|
Oligo in 2nd Tri |
•Poor prognosis from pulmonary hypoplasia |
|
Oligo Causes |
•Demise, infection, UT anomalies, pre eclampsia, IUGR, PROM |
|
AFV at 12 Wks |
•60 ml, increaes 20-26 ml/wk •16 wks: 50-100 ml/wk |
|
AFV at 20 Wks |
•500 ml •Late 3rd tri: 450 ml/day |
|
Before end of 2nd Tri |
•AFV > fetus volume |
|
At End of 2nd Tri |
•AFV = Fetus volume |
|
In 3rd Tri |
•AFV < Fetus volume |
|
Fetal Bladder |
•Cystic structure in pelvis •Fills/empties every 25 mins |
|
3 Areas for UT Evaluation |
•Amniotic fluid volume •For UT anomalies •Other anomalies |
|
Syndromes Assoc With Urinary System |
•Meckel's, VACTERL |
|
Bilateral Renal Agenesis |
•Absent ureteral bud, 1:4000 •Death from pulm hypoplasia |
|
Signs of Agenesis |
•Oligo, absent bladder •Seeing bladder excludes agenesis |
|
Bowel/Adrenals vs Kidneys |
•Color helps ID renal arteries •Look for hypoechoic pyramids |
|
Unilateral Renal Agenesis |
•1:1000, antenatal diagnosis hard •Bowel/adrenal mistaken for kidney •Bladder fills/empties |
|
Urinary Tract Dilatation |
•Can be NL physiologic •4-5 mm 15-24 wks •6-8 mm 24-30 wks •8-10 mm >30 wks |
|
Pelvocaliectasis |
•Seen antenatal, f/u 48 postpartum •Can be reflux |
|
Posterior Urethral Valves |
•Most common urethral obstruction •Flap of skin on post. urethra |
|
Posterior Urethral Valves U/S |
•Persistent dilated bladder •Thick bladder wall, > 2mm •Severe hydro, oligo |
|
Oligo with Posterior Urethral Valves |
•95% won't survive |
|
UVJ Obstruction |
•Duplicated collecting system •UP obstructs, LP refluxes •Ectopic ureterocele |
|
UVJ Obstruction U/S |
•Dilated pelvis, megaureter •Normal AFV, unless bilateral UVJ |
|
UPJ Obstruction |
•Biggest cause of neonatal hydro •Pelvis, infundibula, calyces dilated |
|
UPJ Obstruction U/S |
•Can appear as giant abd cyst •Ureters not dilated •Other kidney & bladder work |
|
Unilateral UPJ Assoc With |
•Contra multicystic dysplasia, renal agenesis or oligo, if severe |
|
Obstructive Renal Dysplasia(Potter's IV) |
•From UPJ, UVJ or bladder obs |
|
Obstructed Renal Dysplasia U/S |
•Obstructed pelvis •Severely hyperechoic cortex •Cortical cysts |
|
MCDK(Potter's II) |
•From atresia of upper uereter, pelvis, infundibulum |
|
MCDK U/S |
•NV pelvis, unilateral, macrocysts •Contra renal anomalies, agenesis |
|
Inherited Syndrome with MCDK |
•Meckel Gruber, short rib polydactyly, Trisomy 13 |
|
PCKD |
•Rec or dom, both kidneys •Low chance of survival if severe |
|
Infantile PCKD(Potter's I) |
•Autorecessive, non obstructive •Oligo, hyperechoic, large kidneys |
|
Adult PCKD(Potter's III) |
•Bilateral large hyperechoic kidneys •Cysts don't dominate kidneys •Normal AFV, not seen antenatally |
|
Prune Belly Syndrome |
•Urethral obstruction •Anterior abd wall distended •Cryptorchidism |
|
Prune Belly U/S |
•Oligo, distended, thick bladder •Hydroureter, bilat hydro •Patent urachus, small thorax |
|
Mesoblastic Nephroma |
•Mostly solid mass in kidney •May be cystic, assoc w/ poly |
|
Hydrops Fetalis |
•Excessive fluid in fetus •Edema, ascites, effusions, poly |
|
Fetal Ansarca |
•Generalized edema |
|
Immune Hydrops |
•Maternal blood cells destroy others •Fetal cells enter maternal system |
|
Immune Response Setup |
•During delivery(most common) •Fetal-maternal hemorrhage |
|
Subsequent Pregnancies |
•MNL antibodies cross P-F barrier •Antibodies attach to antigens •Attack cells, fetal anemia results |
|
Erythroblastosis Fetalis |
•Immature RBCs produced •Hepatomegaly, placental edema, pleural effusions |
|
Hydrops Fetalis U/S |
•Ascites, skin edema, PE •Poly, placenta edema/enlargement •Pericardial effusion |
|
Immune Hydrops Prevention |
•Rhogam, amniocentesis |
|
Non-Immune Hydrops |
•Not immunologic, other causes •No lab tests, high mortality •Non immune if absent antibodies |
|
Non-Immune Hydrops U/S |
•Same as immune •Structural anomalies, most heart •Can have oligo |
|
Non-Immune Hydrops Structural Anomalies |
•Congenital lymphangiectasia, arrhythmias, CCAM |
|
Non-Immune Hydrops Causes |
•TORCH, Parvovirus |
|
Maternal Hypertensive Disease |
•Chronic hypertension disease •Pregnancy induced hypertension |
|
Pregnancy Induced Hypertension |
•Appears late in preg, disappears postpartum |
|
Pre Eclampsia |
•Hypertension, proteinuria, edema •During last 20 wks |
|
Eclampsia |
•Convulsions, coma |
|
PIH Onset Signs |
•Sudden weight gain/high BP, edema, proteinuria •Headaches, blurred vision, EG pain |
|
PIH Fetus |
•Decreased liver blood flow •Low oxygen/nourishment •Premature labor, abruptions |
|
If Patient Becomes Eclamptic |
•Deliver fetus ASAP |
|
PIH U/S |
•IUGR, oligo •Hetero placenta, early separation, decreased volume, increased vasc resistance |
|
Diabetes Maternal Complications |
•Hypoglycemia, poly, PIH, vasc disease, renal dysfunction |
|
Diabetes Fetal Complications |
•Defects, IUGR, SUA, macrosomia |
|
Assoc With SUA |
•Cardiac anomalies, pulmonary hypoplasia, polydactyly |
|
IUGR |
•Uteroplacental vasc insufficiency |
|
Macrosomia |
•Fetal hyperinsulinemia from maternal hyperglycemia •>4000g, or above 90th percentile |
|
Gestaional Diabetes |
•Develops during pregnancy •25 in 1000 pregnancies |
|
Gestational Diabetes Risk Factors |
•Previous stillbirth, F/Hx of diabetes •Prior macrosomia or anomalies |
|
IUGR Considered |
•Small for gestational age •<2500g(5lbs8ozs), or 10th percentile |
|
IUGR Etiologies |
•Maternal disease states •Congenital anomalies/infection •Primary placental pathology |
|
Maternal Disease States |
•Diabetes mellitus, chronic HTN, Rh disease, drugs, high altitude |
|
Maternal Disease States Results |
•Uteroplacental insufficiency •Poor placental perfusion •Oxygen/nutrition deprivation |
|
Congenital Anomalies/Infection |
•CHD, CNS anomalies, 21, 18, 13 •TORCH |
|
Primary Placental Pathology |
•Infarction, previa, abruption •Leads to uteroplacental insufficiency |
|
Symmetrical IUGR |
•Proportionately small fetus •All measurments below 10th % •As early as 20 weeks MA |
|
Symmetrical IUGR Causes |
•Congenital anomalies, trisomies, intrauterine infection, FAS, maternal malnutrition |
|
Asymmetrical IUGR |
•Disproportion between head/body •Body severely affected, liver 1st •Brain sparing |
|
Brain Sparing |
•Head last affected to prevent brain damage |
|
Asymmetrical IUGR MDS |
•Chronic HTN/renal disease, severe diabetes, cardiovascular disease |
|
Asymmetrical IUGR Placental Abruption |
•Smoking, drugs, multiple pregnancies |
|
IUGR U/S Exam |
•Compare interval growth •HC/AC, FL/AC, FL/BPD, weight •Doppler MCA, umbilical artery |
|
Uterine Artery Doppler 1st Tri |
•Persistent diastole with early notch |
|
S/D Ratios |
•10 wks: 3 •13 wks: 2.6 •26 wks: 2 |
|
Uterine Artery PI |
•NL: <1.24 •Abnl: >1.67 •AMA: high risk SGA, preterm |
|
IUGR Treatment |
•Bed rest on left side, relieves IVC •Anti-coagulants: heparin |
|
IUGR Outcomes |
•More often in males •Speech defects, CNS abnormalities |
|
Fetal Maladaption Syndrome |
•Fetus unable to compensate •Oligo, abnl fetal/umbilical Doppler |
|
Perinatal IUGR |
•Intrapartum fetal stress •Hypo/hyperglycemia •Hypothermia, encephalopathy |
|
Childhood IUGR |
•Hypertension, poor neural outcome |
|
Adult IUGR |
•Cardiovascular disease •Hypertension, diabetes |
|
Multiple Gestations Incidence |
•1% of all births •Highest in blacks, lowest in Asians |
|
Multiple Gestations Increases With |
•AMA, parity, heredity, fertility drugs |
|
Multiple Gestations Maternal Risks |
•PIH, preterm labor, edema, 3rd tri hemorrhage, varicosities |
|
Multiple Gestations Fetal Risks |
•Congenital anomalies 2× more •IUGR, discordant growth, PROM •Prematurity, RDS, cerebral hem |
|
Discordant Growth |
•Smaller, > risk of prenatal anoxia •Normal growth till 31-32 wks |
|
Discordant Growth U/S |
•5mm or more diff in BPD •20mm or more diff in AC •Oligo, abnl umb artery Doppler |
|
Dizygotic Twins |
•Fraternal, non identical •2 chorions/2 placentas •2 amnions, thick membrane |
|
Monozygotic Twins |
•Identical, 1 zygote splits •Single chorion, 1 or 2 sacs •Riskier than dizygotic |
|
Twin to Twin Transfusion(Mono Only) |
•Arteriovenous shunt in placenta •Arterial blood of 1 twin pumped into venous system of other |
|
TTT Donor Twin |
•Arterial shunted to recipient •Becomes hypovolemic •Stuck twin if severe |
|
Hypovolemic Twin |
•Growth retarded, poor renal perfusion, anuria, severe oligo |
|
TTT Recipient Twin Hypervolemic |
•Symmetrical size increase •Poly, CHF, hydrops, demise |
|
TTT U/S Criteria |
•Same sex fetuses, single placenta •Thin membrane, 20% weight diff •Twin poly-oli sequence(stuck) |
|
TTT Doppler |
•Decreased diastolic flow •>.4 S/D difference between twins |
|
Quintero Staging System |
•Determines TTT severity •AFV, bladder size, Doppler, hydrops |
|
Quintero Stage I |
•Donor twin bladder visible •Poly-oli sequence |
|
Quintero Stage II |
•Collapsed/NV donor bladder •No CADS |
|
Quintero Stage III |
•CADS: Absent/reverse EDS in UA, reverse DV flow, UV pulsatile |
|
Quintero Stage IV |
•Fetal hydrops |
|
Quintero Stage V |
•Demise of one or both twins |
|
Conjoined Twins |
•Mono/mono gestations •Division after 13th day •Always same sex |
|
Conjoined Twins U/S |
•Lack of separating membrane •Heads in same plane, poly •>3 vessel cord |
|
Parasitic Twin(Fetus in Fetu) |
•2nd twin in sibling's abd •Benign, distinguish from teratoma |
|
Parasitic Twin Characteristics |
•Benign, in upper abd •May have radiographic evidence of vertebrae |
|
Teratoma vs Parasitic Twin |
•Teratoma in lower abd, ovaries or sacrococcygeal area |
|
TRAP Syndrome |
•Twin Reversed Arterial Perfusion •Results in acardiac twin, 1:3500 |
|
TRAP Develops |
•Anastomoses between twins through placenta •Large art-art and ven-ven shunt |
|
Acardiac Twin |
•Blood enters through fetal aorta •Well developed lower body •Poor development of head/upper |
|
TRAP Donor |
•20% become hydropic due to high output cardiac function |
|
Genetic Defects in Mono Twins |
•Nearly 100% with genetic defects •1 normal, 1 Turner's most common •Higher risk of dev abnormalities |
|
Genetic Defects Dizy Twins |
•Very low incidence since not genetically similar |
|
Multi Gestation Polyhydramnios |
•5-10% of all twins •Chronic or acute |
|
Chronic Polyhydramnios |
•Develops over wks in 3rd tri •Increased mortality rate(45%) |
|
Acute Polyhydramnios |
•Develops over days, in wks 20-26 •Mostly in dizygotic, 100% mortality |
|
Selective Termination |
•Improves best survival chance •Only on confirmed dichorionic |
|
Selective Termination Process |
•Inject air into heart or UV •Exsanguination by cardiac puncture |
|
Selective Termination in Mono |
•Can cause thromboplastic response from terminated into suriving •Brain/multi organ damage or death |
|
Signs of Fetal Demise |
•Coarsing of outline, scalp edema, absent heart/somatic movement •Robert's, Spaulding's, Trunk |
|
Coarsing of Outline |
•Edema, AF seeps into skin |
|
Scalp Edema |
•May occur with severe diabetes, Rh sensitivity, fetal anemia |
|
Robert's Sign |
•Gas in fetal vascular system |
|
Spaulding's Sign |
•Overlapping of fetal skull bones •Unable to see falx |
|
Trunk Changes |
•Difficult to ID abd organs •Compressed, coarse outline |